Exploring the potential cost-effectiveness and societal burden implications of screening for fracture risk in a UK general radiography setting
IBEX BH could be a cost-effective tool for early identification and prevention of fragility fractures in the UK, addressing the current challenges of low provision and access to fracture risk assessment and treatment.
Authors
- Peter L. Lewis (ORCID: https://orcid.org/0000-0003-2641-3754)
- Thomas G. Bean (ORCID: https://orcid.org/0000-0002-3577-1994)
- Robert M. Meertens (ORCID: https://orcid.org/0000-0002-2120-8877)
- Nicholas Ashley
- Cesar D. Lopez (ORCID: https://orcid.org/0000-0003-3290-0639)
- Emma Söreskog (ORCID: https://orcid.org/0000-0003-1302-387X)
- Joanita Da Palma Lopes
- A. Ratcliffe
Institutions
- University of Exeter (GB)
- Royal Cornwall Hospital (GB)
- Karolinska Institutet (SE)
- Ibex Innovations (United Kingdom) (GB)
Publication Details
- Journal
- BMC Musculoskeletal Disorders
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1186/s12891-024-08202-6
- Citations
- 2
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 3.44